| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |